|
2025-02-06 |
2025-02-05 |
S
Sale
|
Santos David A
EVP, Chief Commercial Officer
Officer
|
1,796
-3.4%
21.93
USD 39,379
|
1,796
-3.4%
|
21.93
|
USD 39,379
|
|
|
2025-02-06 |
2025-02-05 |
S
Sale
|
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Officer
|
1,339
-3.3%
21.93
USD 29,359
|
1,339
-3.3%
|
21.93
|
USD 29,359
|
|
|
2025-02-06 |
2025-02-05 |
S
Sale
|
RODRIGUEZ RAUL R
CEO, President
Executive Director
|
4,400
-1.8%
21.93
USD 96,474
|
4,400
-1.8%
|
21.93
|
USD 96,474
|
|
|
2025-02-06 |
2025-02-05 |
S
Sale
|
Schorno Dean L
EVP & Chief Financial Officer
Officer
|
1,734
-2.9%
21.93
USD 38,020
|
1,734
-2.9%
|
21.93
|
USD 38,020
|
|
|
2025-02-06 |
2025-02-04 |
S
Sale
|
Santos David A
EVP, Chief Commercial Officer
Officer
|
2,125
-3.8%
20.92
USD 44,457
|
2,125
-3.8%
|
20.92
|
USD 44,457
|
|
|
2025-02-06 |
2025-02-04 |
S
Sale
|
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Officer
|
1,448
-3.5%
20.92
USD 30,294
|
1,448
-3.5%
|
20.92
|
USD 30,294
|
|
|
2025-02-06 |
2025-02-04 |
S
Sale
|
RODRIGUEZ RAUL R
CEO, President
Executive Director
|
4,952
-2.0%
20.92
USD 103,601
|
4,952
-2.0%
|
20.92
|
USD 103,601
|
|
|
2025-02-06 |
2025-02-04 |
S
Sale
|
Schorno Dean L
EVP & Chief Financial Officer
Officer
|
2,036
-3.3%
20.92
USD 42,595
|
2,036
-3.3%
|
20.92
|
USD 42,595
|
|
|
2024-02-06 |
2024-02-05 |
S
Sale
|
RODRIGUEZ RAUL R
CEO, President
Executive Director
|
30,545
-1.5%
1.14
USD 34,821
|
30,545
-1.5%
|
1.14
|
USD 34,821
|
|
|
2024-02-06 |
2024-02-05 |
S
Sale
|
Schorno Dean L
EVP & Chief Financial Officer
Officer
|
7,027
-1.7%
1.14
USD 8,011
|
7,027
-1.7%
|
1.14
|
USD 8,011
|
|
|
2024-02-06 |
2024-02-05 |
S
Sale
|
Santos David A
EVP, Chief Commercial Officer
Officer
|
8,918
-2.5%
1.14
USD 10,167
|
8,918
-2.5%
|
1.14
|
USD 10,167
|
|
|
2024-02-06 |
2024-02-02 |
S
Sale
|
RODRIGUEZ RAUL R
CEO, President
Executive Director
|
22,349
-1.1%
1.13
USD 25,261
|
22,349
-1.1%
|
1.13
|
USD 25,261
|
|
|
2024-02-06 |
2024-02-02 |
S
Sale
|
Schorno Dean L
EVP & Chief Financial Officer
Officer
|
5,601
-1.3%
1.13
USD 6,327
|
5,601
-1.3%
|
1.13
|
USD 6,327
|
|
|
2024-02-06 |
2024-02-02 |
S
Sale
|
Santos David A
EVP, Chief Commercial Officer
Officer
|
5,601
-1.5%
1.13
USD 6,329
|
5,601
-1.5%
|
1.13
|
USD 6,329
|
|
|
2023-02-07 |
2023-02-06 |
S
Sale
|
RODRIGUEZ RAUL R
CEO, President
Executive Director
|
20,340
-1.2%
1.75
USD 35,595
|
20,340
-1.2%
|
1.75
|
USD 35,595
|
|
|
2023-02-06 |
2023-02-02 |
S
Sale
|
Schorno Dean L
EVP & Chief Financial Officer
Officer
|
5,389
-2.7%
1.66
USD 8,946
|
5,389
-2.7%
|
1.66
|
USD 8,946
|
|
|
2023-02-06 |
2023-02-02 |
S
Sale
|
Santos David A
EVP, Chief Commercial Officer
Officer
|
5,388
-3.6%
1.66
USD 8,945
|
5,388
-3.6%
|
1.66
|
USD 8,945
|
|
|
2023-02-06 |
2023-02-02 |
S
Sale
|
Dummer Wolfgang
EVP & CMO
Officer
|
5,389
-6.9%
1.66
USD 8,946
|
5,389
-6.9%
|
1.66
|
USD 8,946
|
|
|
2022-06-13 |
2022-06-09 |
B
Purchase
|
RODRIGUEZ RAUL R
CEO, President
Executive Director
|
1,000,000
+255.2%
0.69
USD 688,400
|
1,000,000
+255.2%
|
0.69
|
USD 688,400
|
|
|
2019-05-23 |
2019-05-22 |
B
Purchase
|
Schorno Dean L
EVP &Chief Financial Officer
Officer
|
3,274
+7.0%
2.13
USD 6,971
|
3,274
+7.0%
|
2.13
|
USD 6,971
|
|
|
2019-05-23 |
2019-05-22 |
B
Purchase
|
Schorno Dean L
EVP &Chief Financial Officer
Officer
|
46,726
+inf%
2.13
USD 99,573
|
46,726
+inf%
|
2.13
|
USD 99,573
|
|
|
2018-10-16 |
2018-10-12 |
PS
Planned sale
|
Cabatuan Nelson
Principal Accounting Officer
Officer
|
10,000
-99.4%
3.12
USD 31,200
|
10,000
-99.4%
|
3.12
|
USD 31,200
|
|
|
2018-09-19 |
2018-09-17 |
PS
Planned sale
|
Duliege Anne-Marie
EVP & Chief Medical Officer
Officer
|
37,500
-100.0%
3.50
USD 131,250
|
37,500
-100.0%
|
3.50
|
USD 131,250
|
|
|
2018-09-19 |
2018-09-17 |
PS
Planned sale
|
Duliege Anne-Marie
EVP & Chief Medical Officer
Officer
|
115,500
-100.0%
3.50
USD 404,250
|
115,500
-100.0%
|
3.50
|
USD 404,250
|
|
|
2018-09-12 |
2018-09-11 |
B
Purchase
|
Mayer Eldon C. III
EVP & Chief Commercial Officer
Officer
|
50,000
+30.3%
3.23
USD 161,340
|
50,000
+30.3%
|
3.23
|
USD 161,340
|
|
|
2018-09-12 |
2018-09-10 |
B
Purchase
|
Mayer Eldon C. III
EVP & Chief Commercial Officer
Officer
|
50,000
+43.5%
3.28
USD 164,210
|
50,000
+43.5%
|
3.28
|
USD 164,210
|
|
|
2018-09-06 |
2018-09-04 |
PS
Planned sale
|
Duliege Anne-Marie
EVP & Chief Medical Officer
Officer
|
16,500
-100.0%
3.51
USD 57,861
|
16,500
-100.0%
|
3.51
|
USD 57,861
|
|
|
2018-08-27 |
2018-08-23 |
PP
Planned purchase
|
Mayer Eldon C. III
EVP & Chief Commercial Officer
Officer
|
100,000
+666.7%
2.82
USD 282,320
|
100,000
+666.7%
|
2.82
|
USD 282,320
|
|
|
2018-08-21 |
2018-08-17 |
PP
Planned purchase
|
RODRIGUEZ RAUL R
CEO, President
Executive Director
|
114,000
+191.5%
2.63
USD 300,002
|
114,000
+191.5%
|
2.63
|
USD 300,002
|
|
|
2018-07-05 |
2018-07-02 |
PS
Planned sale
|
Duliege Anne-Marie
EVP & Chief Medical Officer
Officer
|
5,000
-100.0%
2.79
USD 13,932
|
5,000
-100.0%
|
2.79
|
USD 13,932
|
|
|
2018-04-24 |
2018-04-20 |
PS
Planned sale
|
Duliege Anne-Marie
EVP & Chief Medical Officer
|
5,000
-100.0%
4.11
USD 20,550
|
5,000
-100.0%
|
4.11
|
USD 20,550
|
|
|
2017-11-07 |
2017-11-03 |
PS
Planned sale
|
Maynard Ryan D
EVP & CFO
|
100,000
-100.0%
3.90
USD 390,000
|
100,000
-100.0%
|
3.90
|
USD 390,000
|
|
|
2017-07-07 |
2017-07-05 |
PS
Planned sale
|
Duliege Anne-Marie
Chief Medical Officer
Officer
|
5,000
-100.0%
2.69
USD 13,427
|
5,000
-100.0%
|
2.69
|
USD 13,427
|
|
|
2017-01-13 |
2017-01-03 |
PS
Planned sale
|
Duliege Anne-Marie
Chief Medical Officer
Officer
|
5,000
-100.0%
2.41
USD 12,028
|
5,000
-100.0%
|
2.41
|
USD 12,028
|
|
|
2016-09-01 |
2016-08-30 |
PS
Planned sale
|
PAYAN DONALD G
EVP, Pres. Discovery&Research
Executive Director
|
5,303
-9.1%
4.00
USD 21,214
|
5,303
-9.1%
|
4.00
|
USD 21,214
|
|
|
2015-06-12 |
2015-06-10 |
S
Sale
|
PAYAN DONALD G
EVP, Pres. Discovery&Research
Executive Director
|
41,666
-41.7%
3.68
USD 153,214
|
41,666
-41.7%
|
3.68
|
USD 153,214
|
|
|
2015-04-03 |
2015-04-01 |
S
Sale
|
PAYAN DONALD G
EVP, Pres. Discovery&Research
Executive Director
|
10,000
-14.6%
3.75
USD 37,518
|
10,000
-14.6%
|
3.75
|
USD 37,518
|
|
|
2014-09-05 |
2014-09-03 |
S
Sale
|
PAYAN DONALD G
EVP, Pres. Discovery&Research
Executive Director
|
20,000
-22.6%
2.56
USD 51,200
|
20,000
-22.6%
|
2.56
|
USD 51,200
|
|
|
2014-02-26 |
2014-02-24 |
S
Sale
|
PAYAN DONALD G
EVP, Pres. Discovery&Research
Executive Director
|
20,000
-18.5%
3.71
USD 74,238
|
20,000
-18.5%
|
3.71
|
USD 74,238
|
|
|
2013-11-20 |
2013-11-19 |
S
Sale
|
BVF PARTNERS L P/IL
See Explanation of Responses
Large shareholder
|
153,056
-19.1%
2.64
USD 404,343
|
153,056
-19.1%
|
2.64
|
USD 404,343
|
|
|
2013-11-20 |
2013-11-19 |
S
Sale
|
BVF PARTNERS L P/IL
See Explanation of Responses
Large shareholder
|
331,566
-22.8%
2.64
USD 875,931
|
331,566
-22.8%
|
2.64
|
USD 875,931
|
|
|
2013-06-11 |
2013-06-07 |
B
Purchase
|
BVF PARTNERS L P/IL
See Explanation of Responses
Large shareholder
|
8,102
+1.0%
3.47
USD 28,095
|
8,102
+1.0%
|
3.47
|
USD 28,095
|
|
|
2013-06-11 |
2013-06-07 |
B
Purchase
|
BVF PARTNERS L P/IL
See Explanation of Responses
Large shareholder
|
24,598
+1.7%
3.47
USD 85,298
|
24,598
+1.7%
|
3.47
|
USD 85,298
|
|
|
2012-09-14 |
2012-09-13 |
S
Sale
|
VANCE DOLLY
EVP Corp. Affairs, G.C., Sect.
Officer
|
4,151
-79.0%
10.43
USD 43,284
|
4,151
-79.0%
|
10.43
|
USD 43,284
|
|
|
2012-09-11 |
2012-09-10 |
S
Sale
|
Maynard Ryan D
EVP & CFO
Officer
|
17,586
-100.0%
10.52
USD 184,927
|
17,586
-100.0%
|
10.52
|
USD 184,927
|
|
|
2012-09-14 |
2012-09-07 |
S
Sale
|
Maynard Ryan D
EVP & CFO
Officer
|
23,302
-100.0%
10.67
USD 248,560
|
23,302
-100.0%
|
10.67
|
USD 248,560
|
|
|
2012-09-11 |
2012-09-07 |
S
Sale
|
Maynard Ryan D
EVP & CFO
Officer
|
34,112
-100.0%
10.55
USD 359,960
|
34,112
-100.0%
|
10.55
|
USD 359,960
|
|
|
2012-08-09 |
2012-08-07 |
S
Sale
|
Maynard Ryan D
EVP & CFO
Officer
|
300
-100.0%
10.63
USD 3,188
|
300
-100.0%
|
10.63
|
USD 3,188
|
|
|
2012-08-09 |
2012-08-07 |
S
Sale
|
Maynard Ryan D
EVP & CFO
Officer
|
600
-66.7%
10.62
USD 6,372
|
600
-66.7%
|
10.62
|
USD 6,372
|
|
|
2012-08-09 |
2012-08-07 |
S
Sale
|
Maynard Ryan D
EVP & CFO
Officer
|
100
-10.0%
10.61
USD 1,061
|
100
-10.0%
|
10.61
|
USD 1,061
|
|
|
2012-08-09 |
2012-08-07 |
S
Sale
|
Maynard Ryan D
EVP & CFO
Officer
|
700
-41.2%
10.60
USD 7,420
|
700
-41.2%
|
10.60
|
USD 7,420
|
|
|
2012-06-20 |
2012-06-19 |
S
Sale
|
PAYAN DONALD G
EVP, Pres. Discovery&Research
Executive Director
|
100
-0.1%
8.71
USD 871
|
100
-0.1%
|
8.71
|
USD 871
|
|
|
2012-06-20 |
2012-06-19 |
S
Sale
|
PAYAN DONALD G
EVP, Pres. Discovery&Research
Executive Director
|
9,700
-8.2%
8.70
USD 84,390
|
9,700
-8.2%
|
8.70
|
USD 84,390
|
|
|
2012-06-20 |
2012-06-19 |
S
Sale
|
PAYAN DONALD G
EVP, Pres. Discovery&Research
Executive Director
|
100
-0.1%
8.72
USD 872
|
100
-0.1%
|
8.72
|
USD 872
|
|
|
2012-06-20 |
2012-06-19 |
S
Sale
|
PAYAN DONALD G
EVP, Pres. Discovery&Research
Executive Director
|
100
-0.1%
8.75
USD 875
|
100
-0.1%
|
8.75
|
USD 875
|
|
|
2011-06-07 |
2011-05-26 |
B
Purchase
|
Flynn James E
Large shareholder
|
301,424
+10.4%
8.00
USD 2,411,392
|
301,424
+10.4%
|
8.00
|
USD 2,411,392
|
|
|
2011-06-07 |
2011-05-26 |
B
Purchase
|
Flynn James E
Large shareholder
|
229,252
+11.2%
8.00
USD 1,834,016
|
229,252
+11.2%
|
8.00
|
USD 1,834,016
|
|
|
2011-06-07 |
2011-05-26 |
B
Purchase
|
Flynn James E
Large shareholder
|
72,800
+10.6%
8.00
USD 582,400
|
72,800
+10.6%
|
8.00
|
USD 582,400
|
|
|
2011-06-07 |
2011-05-26 |
B
Purchase
|
Flynn James E
Large shareholder
|
46,524
+11.0%
8.00
USD 372,192
|
46,524
+11.0%
|
8.00
|
USD 372,192
|
|
|
2010-11-05 |
2010-11-03 |
S
Sale
|
Flynn James E
Large shareholder
|
3,690
-0.1%
7.55
USD 27,860
|
3,690
-0.1%
|
7.55
|
USD 27,860
|
|
|
2010-11-05 |
2010-11-03 |
S
Sale
|
Flynn James E
Large shareholder
|
2,605
-0.1%
7.55
USD 19,668
|
2,605
-0.1%
|
7.55
|
USD 19,668
|
|
|
2010-11-05 |
2010-11-03 |
S
Sale
|
Flynn James E
Large shareholder
|
900
-0.1%
7.55
USD 6,795
|
900
-0.1%
|
7.55
|
USD 6,795
|
|
|
2010-11-05 |
2010-11-03 |
S
Sale
|
Flynn James E
Large shareholder
|
516
-0.1%
7.55
USD 3,896
|
516
-0.1%
|
7.55
|
USD 3,896
|
|
|
2007-08-10 |
2007-08-09 |
B
Purchase
|
Goodwin Bradford S
Non-Executive Director
|
5,000
+100.0%
10.00
USD 50,000
|
5,000
+100.0%
|
10.00
|
USD 50,000
|
|
|
2007-08-10 |
2007-08-09 |
B
Purchase
|
Goodwin Bradford S
Non-Executive Director
|
1,815
+57.0%
9.87
USD 17,914
|
1,815
+57.0%
|
9.87
|
USD 17,914
|
|
|
2007-08-10 |
2007-08-09 |
B
Purchase
|
Goodwin Bradford S
Non-Executive Director
|
1,385
+76.9%
9.86
USD 13,656
|
1,385
+76.9%
|
9.86
|
USD 13,656
|
|
|
2007-08-10 |
2007-08-09 |
B
Purchase
|
Goodwin Bradford S
Non-Executive Director
|
800
+80.0%
9.85
USD 7,880
|
800
+80.0%
|
9.85
|
USD 7,880
|
|
|
2007-08-10 |
2007-08-09 |
B
Purchase
|
Goodwin Bradford S
Non-Executive Director
|
600
+150.0%
9.84
USD 5,904
|
600
+150.0%
|
9.84
|
USD 5,904
|
|
|
2007-08-10 |
2007-08-09 |
B
Purchase
|
Goodwin Bradford S
Non-Executive Director
|
100
+33.3%
9.82
USD 982
|
100
+33.3%
|
9.82
|
USD 982
|
|
|
2007-08-10 |
2007-08-09 |
B
Purchase
|
Goodwin Bradford S
Non-Executive Director
|
300
+inf%
9.80
USD 2,940
|
300
+inf%
|
9.80
|
USD 2,940
|
|
|
2007-05-29 |
2007-05-29 |
B
Purchase
|
Grossbard Elliott B
Sr. VP Medical Development
Officer
|
2,000
+inf%
9.68
USD 19,351
|
2,000
+inf%
|
9.68
|
USD 19,351
|
|
|
2005-12-08 |
2005-12-07 |
B
Purchase
|
COOPER ROBIN D G
Sr. V.P. Pharmaceutical Scs.
Officer
|
1,000
+12.5%
8.12
USD 8,120
|
1,000
+12.5%
|
8.12
|
USD 8,120
|
|
|
2005-07-27 |
2005-07-27 |
S
Sale
|
DELEAGE JEAN
Non-Executive Director
|
1,590
-12.1%
20.55
USD 32,671
|
1,590
-12.1%
|
20.55
|
USD 32,671
|
|
|
2005-07-27 |
2005-07-27 |
S
Sale
|
DELEAGE JEAN
Non-Executive Director
|
43,210
-12.0%
20.55
USD 887,879
|
43,210
-12.0%
|
20.55
|
USD 887,879
|
|
|
2005-07-27 |
2005-07-26 |
S
Sale
|
DELEAGE JEAN
Non-Executive Director
|
4,513
-25.5%
20.26
USD 91,419
|
4,513
-25.5%
|
20.26
|
USD 91,419
|
|
